Mechanism of action: Activates GLP-1 receptors in the brain, gut, and pancreas Reduces appetite and food cravings Slows gastric emptying you feel full longer Stimulates insulin release, suppresses glucagon Improves blood sugar regulation FDA-approved brand names: Wegovy 2.4mg weekly, approved for chronic weight management Ozempic approved for type 2 diabetes
Keep sealed until point of use
So the case for oral options isnt that injections are bad its optionality
The addition of glucagon receptor activation introduces direct thermogenic and lipolytic effects that neither GLP-1 nor GIP agonism provides alone, creating a mechanism that, in some ways, bridges the gap between the direct fat-targeting approach of AOD 9604 and the systemic metabolic reprogramming of tirzepatide
None of them have been clinically validated for transdermal delivery
When the drug stops, and at some point it will, those habits are not there